241 related articles for article (PubMed ID: 21549569)
1. Antiprotozoal compounds: state of the art and new developments.
Astelbauer F; Walochnik J
Int J Antimicrob Agents; 2011 Aug; 38(2):118-24. PubMed ID: 21549569
[TBL] [Abstract][Full Text] [Related]
2. Antiparasitic therapy.
Kappagoda S; Singh U; Blackburn BG
Mayo Clin Proc; 2011 Jun; 86(6):561-83. PubMed ID: 21628620
[TBL] [Abstract][Full Text] [Related]
3. Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease.
Future Med Chem; 2013 Oct; 5(15):1709-18. PubMed ID: 24144408
[TBL] [Abstract][Full Text] [Related]
4. Agrochemicals against malaria, sleeping sickness, leishmaniasis and Chagas disease.
Witschel M; Rottmann M; Kaiser M; Brun R
PLoS Negl Trop Dis; 2012; 6(10):e1805. PubMed ID: 23145187
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
Orosco D; Mendoza AR; Meléndez CM
Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
[TBL] [Abstract][Full Text] [Related]
6. Parasitology. Drugs to combat tropical protozoan parasites.
Gelb MH; Hol WG
Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
[No Abstract] [Full Text] [Related]
7. Alkaloids with antiprotozoal activity.
Osorio EJ; Robledo SM; Bastida J
Alkaloids Chem Biol; 2008; 66():113-90. PubMed ID: 19025098
[No Abstract] [Full Text] [Related]
8. Collaborative actions in anti-trypanosomatid chemotherapy with partners from disease endemic areas.
Dujardin JC; González-Pacanowska D; Croft SL; Olesen OF; Späth GF
Trends Parasitol; 2010 Aug; 26(8):395-403. PubMed ID: 20538522
[TBL] [Abstract][Full Text] [Related]
9. The chemotherapy of protozoal infections of man.
Steck EA
J Protozool; 1981 Feb; 28(1):10-6. PubMed ID: 6788942
[No Abstract] [Full Text] [Related]
10. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.
Kaiser M; Mäser P; Tadoori LP; Ioset JR; Brun R
PLoS One; 2015; 10(8):e0135556. PubMed ID: 26270335
[TBL] [Abstract][Full Text] [Related]
11. π-Delocalized Lipophilic Cations as New Candidates for Antimalarial, Antitrypanosomal and Antileishmanial Agents: Synthesis, Evaluation of Antiprotozoal Potency, and Insight into Their Action Mechanisms.
Takasu K
Chem Pharm Bull (Tokyo); 2016; 64(7):656-67. PubMed ID: 27373622
[TBL] [Abstract][Full Text] [Related]
12. Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis.
World Health Organization
World Health Organ Tech Rep Ser; 2012; (975):v-xii, 1-100. PubMed ID: 23484340
[TBL] [Abstract][Full Text] [Related]
13. Hybrid Molecules: Promising Compounds for the Development of New Treatments Against Leishmaniasis and Chagas Disease.
Cardona-G W; Yepes AF; Herrera-R A
Curr Med Chem; 2018; 25(30):3637-3679. PubMed ID: 29521209
[TBL] [Abstract][Full Text] [Related]
14. Innovative lead compounds and formulation strategies as newer kinetoplastid therapies.
Espuelas S; Plano D; Nguewa P; Font M; Palop JA; Irache JM; Sanmartín C
Curr Med Chem; 2012; 19(25):4259-88. PubMed ID: 22834813
[TBL] [Abstract][Full Text] [Related]
15. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and molecular mechanisms of drug resistance in parasites.
Ouellette M
Trop Med Int Health; 2001 Nov; 6(11):874-82. PubMed ID: 11703841
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
18. Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option.
Sbaraglini ML; Vanrell MC; Bellera CL; Benaim G; Carrillo C; Talevi A; Romano PS
Curr Top Med Chem; 2016; 16(19):2201-22. PubMed ID: 26881713
[TBL] [Abstract][Full Text] [Related]
19. Update on the major imported protozoan infections in travelers and migrants.
Norman FF; Comeche B; Chamorro S; Pérez-Molina JA; López-Vélez R
Future Microbiol; 2020 Feb; 15():213-225. PubMed ID: 32065535
[TBL] [Abstract][Full Text] [Related]
20. Boron-based drugs as antiprotozoals.
Jacobs RT; Plattner JJ; Keenan M
Curr Opin Infect Dis; 2011 Dec; 24(6):586-92. PubMed ID: 22001943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
